About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a Healthcare company (Biotechnology) with a market capitalization of $82.9B. Its Maz Rating is 4.67 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.27, Growth 3.17, Profitability 4.85, Financial Health 4.60, Momentum 4.00 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

Leonard S. Schleifer

Employees

15,410

IPO date

1991-04-02